Role of interleukin-6 -174 G/C promoter polymorphism in trace metal levels of autopsy kidney and liver tissues

International Journal of Hygiene and Environmental Health

Volumn 214, Issue 3, 2011, Pages 219-224

  Yalçin, Serap ^a   Kayaalti, Zeliha ^a   Söylemezoǧlu, Tülin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Autopsy; Interleukin 6; Kidney; Liver; Metals; Polymorphism

Indexed keywords

INTERLEUKIN 6; TRACE ELEMENT; ZINC;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; AUTOPSY; CHROMOSOME 7; ENVIRONMENTAL EXPOSURE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; KIDNEY; LIVER; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; POPULATION DYNAMICS; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AUTOPSY; CHROMOSOMES, HUMAN, PAIR 7; ENVIRONMENTAL EXPOSURE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; KIDNEY; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POPULATION DYNAMICS; PROMOTER REGIONS, GENETIC; SPECTROPHOTOMETRY, ATOMIC; TRACE ELEMENTS; ZINC;

EID: 79958049728     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2011.01.005     Document Type: Article

References (45)

1. Bonafe M., Olivieri F., Cavallone L., Giovagnetti S., Mayegiani F., Cardelli M., Pieri C., Marra M., Antonicelli R., Lisa R., Rizzo M.R., Paolisso G., Monti D., Franceschi C. A gender dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 2001, 31:2357-2361.
2. Bowcock A.M., Kidd J.R., Lathrop G.M., Daneshvar L., May L.T., Ray A., Sehgal P.B., Kidd K.K., Cavalli-Sforza L.L. The human " interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1988, 3:8-16.
3. Bowcock A.M., Ray A., Erlich H., Sehgal P.B. Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. Nucleic Acids Res. 1989, 17:6855-6864.
4. Budak F., Göral G., Heper Y., Yi{dotless}lmaz E., Aymak F., Baştürk B., Töre O., Ener B., Haluk B. Oral IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine 2007, 38:32-36.
5. Bui L.M., Dressendorfer R.H., Keen C.L., Summary J.J., Dubick M.A. Zinc status and interleukin-1 beta-induced alterations in mineral metabolism in rats. Proc. Soc. Exp. Biol. Med. 1994, 206:438-444.
6. Cui L., Takagi Y., Wasa M., Iiboshi Y., Inoue M., Khan J., Sando K., Nezu R., Okada A. Zinc deficiency enhances interleukin-1 alpha-induced metallothionein-1 expression in rats. J. Nutr. 1998, 128:1092-1098.
7. DeMichele A., Martin A.M., Mick R., Gor P., Wray L., Klein-Cabral M., Athanasiadis G., Colligan T., Stadtmauer E., Weber B. Interleukin-6 -174 GC polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 2003, 63:8051-8056.
8. Erdogan M., Karadeniz M., Berdeli A., Alper G., Caglayan O., Yi{dotless}lmaz C. The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients. J. Endocrinol. Invest. 2008, 31:624-629.
9. Faltraco F., Bürger K., Zill P., Teipel S.J., Möller H.J., Hampel H., Bondy B., Ackenheil M. Interleukin-6 -174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J. Am. Geriatr. Soc. 2003, 51:578-579.
10. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
11. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:7251-7255.
12. Giacconi R., Cipriano C., Albanese F., Boccoli G., Saba V., Olivieri F., Franceschi C., Mocchegiani E. The -174 G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp. Gerontol. 2004, 39:621-628.
13. Grungreiff K. Zinc in liver disease. J. Trace Elem. Exp. Med. 2002, 15:67-78.
14. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K.H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. U.S.A. 1985, 82:5490-5494.
15. Hirano T. The biology of interleukin-6. Chem. Immunol. 1992, 51:153-180.
16. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3489-3494.
17. Jahromi M.M., Millward B.A., Demaine A.G. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J. Interferon Cytokine Res. 2000, 20:885-888.
18. Junji{dotless} H. Historical views of interleukin studies IL-6. Biotherapy 2000, 14:1025-1044.
19. Kagi J.H., Schaffer A. Biochemistry of metallothionein. Biochemistry 1988, 27:8509-8515.
20. Kayaalti{dotless} Z., Mergen G., Söylemezoǧlu T. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population. Toxicol. Appl. Pharmacol. 2010, 245:252-255.
21. Kesarwani P., Ahirwar D., Singh R., Manchanda P.K., Mittal R.D. Do IL-4 intron 3 VNTR and IL-6 (-174) G/C variants reflect ethnic variation? A comparative study between the global and North Indian populations. Asian Pac. J. Cancer Prev. 2008, 9:76-80.
22. Kishimoto T. The biology of interleukin-6. Blood 1989, 74:1-10.
23. Koller L.D. Immunotoxicology of heavy metals. Int. J. Immunopharmacol. 1980, 2:269.
24. Maret W., Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3478-3482.
25. Maret W., Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol. Med. 2007, 13:371-375.
26. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., Mocchegiani E. Effects of interleukin-6 -174 C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp. Gerontol. 2008, 43:423-432.
27. McBean L.D., Dove J.T., Halsted J.A., Smith J.C. Zinc concentration in human tissues. Am. J. Clin. Nutr. 1972, 25:672-676.
28. Miller L.V., Hambidge K.M., Naake V.L., Hong Z., Westcott J.L., Fennessey P.V. Size of the zinc pools that exchange rapidly with plasma zinc in humans: alternative techniques for measuring and relation to dietary zinc intake. J. Nutr. 1994, 124:268-276.
29. Mocchegiani E., Muzzioli M., Cipriano C., Giacconi R. Zinc, T-cell pathways, aging: role of metallothioneins. Mech. Ageing Dev. 1998, 106:183-204.
30. Mocchegiani E., Muzzioli M., Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol. Sci. 2000, 21:205-208.
31. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp. Gerontol. 2002, 37:349-357.
32. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp. Gerontol. 2006, 41:1094-1107.
33. Mocchegiani E., Giacconi R., Costarelli L., Muti E., Cipriano C., Tesei S., Pierpaoli S., Giuli C., Papa R., Marcellini F., Gasparini N., Pierandrei R., Piacenza F., Mariani E., Monti D., Dedoussis G., Kanoni S., Herbein G., Fulop T., Rink L., Jajte J., Malavolta M. Zinc deficiency and IL-6 -174 G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Exp. Gerontol. 2008, 43:433-444.
34. Oldereid N.B., Thomassen Y., Attramadal A., Olaisen B., Purvis K. Concentrations of lead, cadmium and zinc in the tissues of reproductive organs of men. J. Reprod. Fertil. 1993, 99:421-425.
35. Olivieri F., Bonafe M., Cavallone L., Giovagnetti S., Marchegiani F., Cardelli M., Mugianesi E., Giampieri C., Moresi R., Stecconi R., Lisa R., Franceschi C. The -174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp. Gerontol. 2002, 37:309-314.
36. Olomolaiye O., Wood N.A., Bidwell J.L. A novel NlaIII polymorphism in the human IL-6 promoter. Eur. J. Immunogenet. 1998, 25:267.
37. Orłowski C., Piotrowski J.K., Kubów M. The levels of cadmium, zinc and copper in the renal cortex and liver of the inhabitants of the copper basin. Int. J. Occup. Med. Environ. Health 1996, 9:255-263.
38. Prasad A.S. Zinc in human health and disease. J. Assoc. Physicians India 1993, 41:519-521.
39. Prasad A.S. Zinc in human health: an update. J. Trace Elem. Exp. Med. 1998, 11:63-87.
40. Rink L., Gabriel P. Zinc and the immune system. Proc. Nutr. Soc. 2000, 59:541-552.
41. Sekuri C., Cam F.S., Saǧcan A., Ercan E., Tengiz I., Alioǧlu E., Berdeli A. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron. Artery Dis. 2007, 18:333-337.
42. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:9679-9683.
43. Van Snick J. Interferon-6: an overview. Annu. Rev. Immunol. 1990, 8:253-278.
44. Weissenbach J., Chernajovsky Y., Zeevi M., Shulman L., Soreq H., Nir U., Wallach D., Perricaudet M., Tiollais P., Revel M. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:7152-7156.
45. Yasukawa K., Hirano T., Watanabe Y., Muratani K., Matsuda T., Nakai S., Kishimoto T. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 1987, 6:2939-2942.